BRIEF — Renerve Says Positive FDA Feedback On Nervalign Nerve Guide Matrix

Oct 14 (Reuters) — ReNerve Ltd: Positive Fda Feedback On Nervalign Nerve Guide Matrix Receives Positive Fda Feedback For Nervalign Nerve Guide Matrix Further company coverage: RNV.AX (Reuters.Briefs@thomsonreuters.com;)